Case Control Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 659-669
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.659
Table 3 Sensitivity of the Glyco-model in detecting patients with pancreatic ductal adenocarcinoma of different stages
Subgroup
Sensitivity
Overall84.95% (79/93)
Stage I89.66% (26/29)
Stage II77.27% (17/22)
Stage III & IV90.00% (18/20)
Unknown81.82% (18/22)